Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

HOVA EXPECTORANT

Approval Number

SIN03251P

Drug Name

HOVA EXPECTORANT

Product Name

HOVA EXPECTORANT

Approval Date

June 12, 1989

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

SYRUP

Route of Administration

ORAL

Medical Information

ATC Code

R05CA10

ATC Item Name

combinations

Manufacturer Information

Pharmaceutical Manufacturer

GOLDPLUS UNIVERSAL PTE LTD

Manufacturers

HOVID BHD

Active Ingredients

Ingredient Name

SODIUM CITRATE

Strength

57 mg/5 ml

Drug MonographSodium citrate

Ingredient Name

DIPHENHYDRAMINE HCl

Strength

14 mg/5 ml

Drug MonographDiphenhydramine

Ingredient Name

AMMONIUM CHLORIDE

Strength

135 mg/5 ml

Drug MonographAmmonium chloride

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy